Harmony Biosciences Holdings (HRMY) Capital Expenditures (QoQ) (2020 - 2025)
Harmony Biosciences Holdings (HRMY) Capital Expenditures (QoQ) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Harmony Biosciences Holdings | 2.07 Bn | 1.55 Bn | 170.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 50.70% |
| Sep 30, 2025 | 1,675.00% |
| Jun 30, 2025 | -96.88% |
| Mar 31, 2025 | -75.05% |
| Dec 31, 2024 | 17,000.00% |
| Sep 30, 2024 | -99.53% |
| Jun 30, 2024 | 12,540.00% |
| Mar 31, 2024 | -95.33% |
| Sep 30, 2022 | 109.76% |
| Jun 30, 2022 | -8.89% |
| Sep 30, 2021 | -53.73% |
| Jun 30, 2021 | 4,925.00% |
| Mar 31, 2021 | 100.84% |
| Dec 31, 2020 | -137.47% |
| Sep 30, 2020 | 2,319.30% |
| Jun 30, 2020 | 92.21% |
| Mar 31, 2020 | -338.44% |